Skip to main content
NCBI home page
The Journal of General Virology logoLink to The Journal of General Virology
. 2011 Apr;92(Pt 4):919–930. doi: 10.1099/vir.0.027557-0

Genetic and antigenic characterization of H1 influenza viruses from United States swine from 2008

Alessio Lorusso 1, Amy L Vincent 1, Michelle L Harland 1, David Alt 1, Darrell O Bayles 1, Sabrina L Swenson 2, Marie R Gramer 3, Colin A Russell 4, Derek J Smith 4, Kelly M Lager 1, Nicola S Lewis 4
PMCID: PMC3133703  PMID: 21177926

Abstract

Prior to the introduction of the 2009 pandemic H1N1 virus from humans into pigs, four phylogenetic clusters (α-, β-, γ- and δ) of the haemagglutinin (HA) gene from H1 influenza viruses could be found in US swine. Information regarding the antigenic relatedness of the H1 viruses was lacking due to the dynamic and variable nature of swine lineage H1. We characterized 12 H1 isolates from 2008 by using 454 genome-sequencing technology and phylogenetic analysis of all eight gene segments and by serological cross-reactivity in the haemagglutination inhibition (HI) assay. Genetic diversity was demonstrated in all gene segments, but most notably in the HA gene. The gene segments from the 2009 pandemic H1N1 formed clusters separate from North American swine lineage viruses, suggesting progenitors of the pandemic virus were not present in US pigs immediately prior to 2009. Serological cross-reactivity paired with antigenic cartography demonstrated that the viruses in the different phylogenetic clusters are also antigenically divergent.

INTRODUCTION

Influenza in swine is an acute respiratory disease caused by influenza A virus. Influenza A virus contains a negative-sense ssRNA genome organized into eight individual segments, allowing for reassortment and production of novel viruses (Lamb & Krug, 2007). Based upon the major differences within the haemagglutinin (HA) and neuraminidase (NA) proteins, 16 HA and 9 NA subtypes, naturally paired in different combinations, have been identified thus far (Fouchier et al., 2005; Röhm et al., 1996; Webster et al., 1992). HA and NA proteins are encoded by segments 4 and 6 of the viral genome, located on the virion surface, and are the primary target for the host immune response (Skehel & Wiley, 2000). The HA protein is the most important determinant of virulence and host specificity as its binding site and binding pocket recognize sialic acid-containing cell surface receptors on host epithelial cells (Ayora-Talavera et al., 2009; de Wit et al., 2010; Nicholls et al., 2008; Shinya et al., 2006). The remaining six segments encode the following structural and accessory proteins: PB2 (segment 1), PB1 (segment 2), PA (segment 3), NP (segment 5), M1 and M2 (segment 7), NS1 and NS2/NEP (segment 8) (Lamb & Krug, 2007). An additional accessory protein PB1-F2 (Chen et al., 2001) can be encoded by segment 2 as well as the recently identified protein product N40 (Wise et al., 2009), of which little is known. Accessory proteins may confer virulence properties to viruses that express them (McAuley et al., 2007); e.g. PB1-F2 associates with mitochondrial proteins, inducing apoptosis in immune cells (Chen et al., 2001; Zamarin et al., 2006), and NS1 abrogates the expression of antiviral genes in host cells (García-Sastre et al., 1998; Geiss et al., 2002; Lipatov et al., 2005; Seo et al., 2004). Virulence markers as well as factors contributing to inter-species transmission were indentified in the PB2 protein (Gao et al., 2009; Hatta et al., 2001; Mehle & Doudna, 2009; Salomon et al., 2006; Steel et al., 2009; Subbarao et al.,1993; Tarendeau et al., 2008; Yamada et al., 2010; Zhu et al., 2010), whereas antiviral-resistance determinants were found in the NA (Le et al., 2005) and M proteins (Marozin et al., 2002).

Classical H1N1 swine viruses (cH1N1), derived from the 1918 pandemic H1N1, were the unique subtype responsible for infection of US swine (Easterday & van Reeth, 1999) until the introduction of a novel H3N2 virus around 1998 changed the status quo of influenza epidemiology in US swine (Vincent et al., 2008). The H3N2 viruses quickly became endemic and then reassorted with extant cH1N1 influenza viruses circulating in North American swine. The H3N2 viruses were demonstrated to have HA, NA and PB1 genes from viruses originating in humans; PA and PB2 genes from viruses originating in avians; and the remaining internal genes, NP, M and NS, of viruses originating in swine, thus giving rise to the triple reassortant designation (Zhou et al., 1999). The human lineage PB1, avian lineages PB2 and PA and swine lineages NP, M and NS found in contemporary influenza viruses of swine are referred to as the triple reassortant internal gene (TRIG) constellation (Vincent et al., 2008). Reassortant viruses have become endemic and co-circulate in most major swine-producing regions of the USA and Canada, including further drift variants of multiple lineages of H3N2, H1N2 and H1N1 (Vincent et al., 2008). Additionally, introduction of H1 in the TRIG backbone viruses with the HA gene of human virus origin (hu-like H1) that are genetically and antigenically distinct from the classical swine H1 lineage were reported (Vincent et al., 2009a). Therefore, in order to best represent the evolution of the currently circulating H1 viruses, a cluster classification has been proposed (Vincent et al., 2009a). Viruses from the cH1N1 lineage evolved over time to form α-, β- and γ-clusters based on the genetic makeup of the HA gene, whereas H1 subtype strains with HA genes most similar to human seasonal H1 viruses form the δ-cluster. All four HA cluster gene types can be found with NA genes of either the N1 or N2 subtype.

The concern for the role of pigs in the evolution of influenza A viruses was underscored after the outbreak in humans of the novel 2009 pandemic H1N1. The 2009 pandemic H1N1 has been demonstrated to contain six gene segments of the North American triple reassortant swine lineage with the M and NA from the Eurasian lineage H1N1 (Dawood et al., 2009; Garten et al., 2009). Thus, further investigation regarding the genetic and antigenic evolution of North American influenza virus isolates from swine prior to the emergence of 2009 pandemic H1N1 was warranted. Until recently, however, there were no established tools for the quantitative analysis of antigenic data.

In the present study, we characterized 12 2008 field isolates from swine of the H1 subtype influenza virus in two parallel approaches. The first was based on the full genome sequence and phylogenetic analysis of the eight viral gene segments. The genome sequence analysis was carried out by adopting the next generation 454 genome sequencing technology. The second approach used serological cross-reactivity in the haemagglutination inhibition (HI) assay and antigenic cartography. To our knowledge, this study offers the first antigenic mapping of H1 viruses currently circulating in the swine population.

RESULTS

Pyrosequencing technology

The pyrosequencing technology was successfully applied to multiplexed de novo sequencing of up to five viruses per region by use of oligo adaptors containing multiplex identifier (MID). Because of the large number of non-influenza virus sequence reads in preliminary sequencing efforts (background RNA from culture source, i.e. MDCK cells) a two-step sequential sucrose semi-purification was performed in the final sequencing run. Additionally, a quantitative real-time RT-PCR for the matrix gene (Spackman & Suarez, 2008) was utilized to quantify influenza virus-specific RNA prior to cDNA synthesis, and real-time PCR for the same matrix gene target was used to semi-quantify viral cDNA just prior to sequencing. The average percentage of the 12 viral genomes sequenced by the Genome Sequencer was 79 % of approximately 13 500 bases. In most cases, large contigs were assembled by the Newbler software for each gene segment for each virus. Comparison of the large de novo contigs by blast with known influenza sequences allowed lineage identification for all genes. Sanger sequencing using targeted oligo primers was utilized to walk across gaps or clean up sequences. No large contigs were produced for gene segment 8 of A/swine/Ohio/02026/2008, which was subsequently amplified by standard RT-PCR procedures for sequencing.

Genetic characterization

We analysed the virus sequences to elucidate the molecular characteristics in those gene segments previously shown to carry virulence factors. All 2008 H1 swine viruses carrying the avian-lineage PB2, contained an E at position 627, a D residue at position 701 and an R residue at position 591. By sequence analysis of the human-lineage PB1 all viral isolates, with the exception of one, contain the full-length coding sequence for the accessory PB1-F2 product. A/swine/Kentucky/02086/2008 had premature stop codons in the PB1-F2 coding sequence after nine residues as in other published PB1 sequences from extant swine viruses (data not shown). All strains contained an N at position 66 of the PB1-F2 mature product. S66 was reported to be associated with increased virulence in the 1918 H1N1 virus and some highly pathogenic H5N1 avian influenza viruses (Conenello et al., 2007).

Comparison of the HA protein sequences was performed. The 12 2008 H1 isolates contain residues typical of the swine lineage in the receptor-binding pocket with some exceptions: A/swine/Iowa/02039/2008 (δ1 HA cluster) showed an exclusively human lineage G residue at position 68 (according to H1 numbering of the mature peptide with 1 being the first amino acid after the signal sequence); A/swine/Iowa/02039/2008 and A/swine/Texas/01976/2008 (δ1 HA cluster) display 187N residue as in contemporary H1N1/H1N2 human and swine viruses; δ1 and δ2 viruses differ in position 133 with respect to the other clusters showing a human-lineage S residue. Moreover, the presence of 187D (or N) suggests a ‘human’ Neu5Acα2-6Gal receptor binding preference (Matrosovich et al., 2000; Neumann & Kawaoka, 2006). Residues of the receptor-binding pocket and variability in the antigenic epitopes are represented in Fig. 1.

Fig. 1.

Fig. 1.

Open in a new tab

HA1 protein sequence alignment reveals critical amino acid changes between α-, β- γ- and δ-clusters. The 12 2008 H1 predicted HA1 proteins were aligned and compared to that of 2009 pandemic H1N1 (A/MX/4108/2009, GenBank accession no. GQ162170) and A/swine/Minnesota/07002083/2007 (δ2 cluster, GenBank accession no. FJ611898) and numbered using the mature HA1. Two human seasonal influenza viruses HA sequences were included: A/Michigan/2/2003 (GenBank accession no. CY016324) and A/Wisconsin/04/2009 (GenBank accession no. GQ475852). Amino acid differences are visible in the antigenic sites Cb (red), Ca2 (green), Sa (light blue), Sb (violet) and Ca1 (yellow) between the α-, β-, γ-cluster viruses and the human-like δ-cluster viruses. The residues forming the receptor-binding pocket are indicated by a diamond (⋄). Viruses belonging to the δ-cluster preserve remnants of the human lineage. A/swine/Iowa/02039/2008 contains a G (blue) at position 68 and N (violet in the Sb antigenic site) at position 187. The 187N human virus-derived residue is present in A/swine/Texas/01976/2008 as well.

The substitutions H274Y and N294S in the NA protein of N1 viruses have been described to confer resistance to the activity of oseltamivir (Le et al., 2005). All the 2008 H1 swine viruses carrying the N1 gene contained the oseltamivir-sensitive genotype. Residue 31S of the M2 protein was previously shown to confer resistance to antiviral molecules amantadine/rimantadine if mutated to an N residue in European swine H1N1, H1N2 and H3N2 influenza viruses (Marozin et al., 2002). The influenza isolates from US swine analysed here displayed the amantadine-sensitive genotype.

The NS1 genes of the 2008 H1 strains do not possess the deletion at position 80–84 or an E at position 92 previously shown to act as virulence factors (Long et al., 2008; Seo et al., 2002). The 2009 pandemic H1N1 was previously shown to lack CPSF30-binding activity (Hale et al., 2010), and all of the 2008 NS1 protein sequences from swine viruses carry the same 108R, 125E and 189G residues responsible for loss of binding, with the exception of a 189S residue present in A/swine/Missouri/02060/2008.

Phylogenetic analysis

The phylogenetic analysis is shown in Fig. 2(a, b). The 12 selected H1 swine influenza viruses represent each of the four previously described HA phylogenetic clusters found in swine and all have the North American TRIG constellation (Fig. 2a). In addition, the HA from the δ-cluster viruses were shown to have most likely emerged from two separate introductions of human seasonal HA of an H1N2 and an H1N1 (Vincent et al., 2009a) and can be differentiated by two distinct subclusters, δ1 and δ2, respectively (Fig. 2b). Variation was demonstrated in the six genes that make up the TRIG, but no HA cluster-specific patterns were detected among the TRIG genes. Viruses belonging to the δ-cluster were shown to be paired either with an N1 or an N2 gene consistently of human lineage. Importantly, none of the eight genes from the 2008 H1 viruses clustered with the genes of the 2009 pandemic H1N1 that emerged in the human population in the spring of 2009. In all of the phylogenetic analyses of each gene segment, the pandemic H1N1 formed a distinct and independent branch from the US swine lineage genes.

Fig. 2.

Fig. 2.

Fig. 2.

Open in a new tab

(a, b) Full phylogenetic analysis of the 2008 H1 North American isolates. Neighbour-joining trees inferred from multiple nucleotide sequence alignment of (a), PB2 (2280 nt), PB1 (2274 nt), PA (2151 nt), NP (1497 nt), M (982 nt), NS (844 nt) and (b), HA (1701 nt) and NA (1410 nt) gene segments. HA and NA gene sequences of 24 swine and human pandemic H1N1 (including the five isolates included in the antigenic mapping), five classical H1N1 lineage and 15 δ1 isolates were included, but condensed in the HA and NA phylogenetic analyses. Fig. 2(b) HA analysis shows five clusters of related viruses, H1α, H1β, H1γ, H1δ and δ2 as indicated by the bars on the right of the tree. Bars indicate the estimated numbers of nucleotide substitutions per site. The TRIG constellation is indicated by the bar to the right and other lineages are indicated by group labels of compressed branches. The swine HA-cluster specificity of each 2008 virus is indicated in each tree: open diamond, α cluster; closed triangle, β cluster; closed diamond, γ cluster; closed circle, δ cluster; open circle, human seasonal H1N1/N2 influenza viruses; open triangle, 2009 pandemic H1N1. Hu, Human; sw, swine; du, duck; ch, chicken.

Antigenic characterization

Serological cross-reactivity in the HI assay is summarized in Supplementary Tables S1(a, b), available in JGV Online, and the fold-reduction between homologous and heterologous serum and virus pairs is described in Supplementary Tables S1(a, b). Viruses representing the phylogenetic clusters evolved from the cH1N1 swine-lineage demonstrated moderate to strong cross-reactivity within a cluster, especially within recent β- and γ-cluster viruses. However, cross-reactivity between clusters was more variable, ranging from no cross-reactivity to strong cross-reactivity. The lack of cross-reactivity was most dramatically demonstrated between the cH1N1 swine-lineage clusters and the δ-cluster. Indeed, in four of five putative antigenic sites, the δ-cluster viruses contain unique amino acid residues making them dramatically different from the other three clusters (Fig. 1). Additional δ-cluster viruses were tested against swine influenza antisera by HI (J. R. Ciacci-Zanella and others, unpublished data) and added to the antigenic cartography to better place the 2008 δ-cluster viruses. Limited HI cross-reactivity was demonstrated within the δ-cluster overall. Future addition of δ-cluster viruses and antisera will improve their placement in the swine H1 antigenic map. The 2008 H1 viruses tended to be mapped antigenically in accordance with their phylogenetic cluster as demonstrated in Fig. 3, and represent at least five antigenically distinct clusters of H1 viruses co-circulating in US swine in 2008.

Fig. 3.

Fig. 3.

Open in a new tab

Antigenic map of North American swine influenza viruses subtype H1. The relative positions of strains (coloured dots) and swine hyperimmune antisera (open squares) were computed such that the distances between strains and antisera in the map with the least error represent the corresponding HI measurements (Smith et al., 2004). Strain colour indicates α-cluster (cyan), β-cluster (pink), γ-cluster (blue), δ-cluster (gold) and 2009 H1N1 (red). Each grid square represents 1 U of antigenic distance, corresponding to a twofold difference in the HI assay.

Antisera generated against two isolates of 2009 pandemic H1N1 were additionally tested against select 2007–2008 swine H1 viruses and results reported in Table 3(a, b) and included in the antigenic cartography are depicted in Fig. 3. Decreased fold-differences in cross-reactivity were evident between the 2009 pandemic H1N1 antisera and α- and β-cluster influenza isolates from US swine. Moderate cross-reactivity was demonstrated between the 2009 antisera and γ-cluster swine isolates tested (Table 3a, b). No cross-reactivity was found between 2009 pandemic H1N1 antisera and viruses belonging to the δ-cluster (data not shown). Cross-reactivity between swine influenza antisera and 2009 pandemic H1N1 viruses was shown in a recent study (Vincent et al., 2010). Three 2009 pandemic H1N1 isolated from swine (Supplementary Table S3, available in JGV Online) were tested against the 2008 serum panel and included in the antigenic cartography analysis. Human and swine 2009 pandemic H1N1 isolates mapped together in the antigenic cartography (Fig. 3).

Table 3.

(a, b) HI titres for individual swine serum samples (a), fold-reduction compared with homologous HI titre (b)

Reciprocal HI titres for individual serum samples against human isolates of 2009 pandemic H1N1 are reported for 2007–2008 US H1 swine influenza viruses representing the swine-lineage α-, β-, and γ-clusters. p, Pandemic; phylogenetic clusters are indicated by the corresponding letter in front of the virus or antiserum names.

Viruses Sera
p#960A p#962A p#963A p#966A
(a)
p A/CA/04/09 640* 640* 320 320
p A/MX/4108/09 640 640 640* 1280*
α A/Sw/MN/02053/08 10 40 20 20
α A/Sw/MN/02093/08 160 160 40 40
β A/Sw/IA/02096/08 80 80 80 40
β A/Sw/KY/02086/08 80 160 160 80
β A/Sw/NE/02013/08 40 20 80 20
β A/Sw/NC/02084/08 80 160 80 80
γ A/Sw/NC/02023/08 160 160 160 160
γ A/Sw/OH/02026/08 80 80 80 80
γ A/Sw/MO/02060/08 80 80 80 40
γ A/Sw/OH/511445/07 80 80 80 80
(b)
p A/CA/04/09 * * 2 2
p A/MX/4108/09 1 1 * *
α A/Sw/MN/02053/08 64 16 32 32
α A/Sw/MN/02093/08 4 4 16 16
β A/Sw/IA/02096/08 8 8 8 16
β A/Sw/KY/02086/08 8 4 4 8
β A/Sw/NE/02013/08 16 32 8 32
β A/Sw/NC/02084/08 8 4 8 8
γ A/Sw/NC/02023/08 4 4 4 4
γ A/Sw/OH/02026/08 8 8 8 8
γ A/Sw/MO/02060/08 8 8 8 16
γ A/Sw/OH/511445/07 8 8 8 8
Open in a new tab

*Homologous antiserum and virus reactions.

DISCUSSION

The purpose of this study was to characterize the genetic and antigenic properties of 12 representative 2008 H1 influenza viruses isolated from US swine. The viruses were collected the year prior to the emergence and global spread of the 2009 pandemic H1N1 virus and represent the predominant viruses circulating in US swine at that time. The 454 genome sequencing technology described in this report was successfully applied to multiplexed de novo sequencing for nearly all segments of each virus. Large contigs were generated that allowed identification of the sequences as influenza A virus as well as lineage determination. Recent reports using oligo enrichment (Ramakrishnan et al., 2009) or amplicon (Höper et al., 2009) based techniques for 454 sequencing likely improves coverage of the full influenza A virus genome compared with the completely de novo method used here. Advancement in next generation genome sequencing continues to evolve as this relatively new technology is applied to viral RNA genomes.

Genetic diversity was demonstrated in all gene segments, but most notably in the HA gene with five distinct genetic clusters (α-, β-, γ-, δ1 and δ2). All α-, β- and γ-cluster H1 viruses studied were paired with an N1 subtype of the North American swine lineage. The three δ1 were paired with an N2 subtype. In contrast to HA, no patterns of clustering according to H1 cluster could be extended to the genes composing the TRIG. This suggests that reassortment and drift of the H1 HA is occurring randomly on the TRIG backbone. None of the δ-cluster sequences used in the phylogenetic analysis from our virus set or published sequences were paired with a swine-lineage N1 as found for viruses in the α-, β- and γ-clusters. Thus, the human-lineage δ-cluster HA shows a unique preference for the human-lineage N1 and N2. The human N2 gene was introduced into pigs nearly 10 years ago (Vincent et al., 2008) and is now well-established in the swine population. The human-lineage N2 from the H3N2 viruses are closely related to the NA genes of the seasonal human H1N2 from which the δ1 viruses evolved. An optimal ‘HA/NA pairing’ in association with the TRIG could be advantageous for the virus in terms of transmission and replication properties as confirmed by recent experiments in pigs (Ma et al., 2010).

The influenza virus polymerase plays a critical role in the adaptation of avian viruses to mammalians. Generally, aa 627 in the PB2 protein is almost exclusively K in human influenza isolates and E in avian influenza isolates (Subbarao et al., 1993). Additionally, the mutation E627K was found to be responsible for host range, tissue tropism and increased virulence of avian viruses in mammals (Fouchier et al., 2004; Gao et al., 2009). In addition, a D701N amino acid change has been found to confer high pathogenicity to an H5N1 in experimentally infected mice (Li et al., 2005). Mammalian-type residues K627 and N701 are found in some H5N1 or H7N7 (Fouchier et al., 2004) and are implicated in expanding the transmission range in ferrets (Van Hoeven et al., 2009) and guinea pigs (Steel et al., 2009). The 2009 pandemic H1N1 possess E627 and an R591 that has been recently recognized to sustain efficient replication in mammalian cells, compensating for the lack of K627 (Mehle & Doudna, 2009; Yamada et al., 2010). Of the publicly available swine TRIG PB2 sequences, approximately 30 % contain R591 (Mehle & Doudna, 2009). Accordingly, the entire panel of the 2008 TRIG H1 isolates reported in this study contained PB2-R591, suggesting that this genotype may be selected in the swine host. Additional PB2 sequence analysis and evaluation in vivo in swine is warranted.

Antigenic cartography is a theory and associated computational method that resolves the paradoxes in the interpretation of antigenic data and makes possible high-resolution quantitative analyses and visualization of binding assay data (de Jong et al., 2007; Garten et al., 2009; Huang et al., 2009; Park et al., 2009; Russell et al., 2008; Smith et al., 2004). By using antigenic cartography and phylogenetic analysis, we showed that five antigenic (α-, β-, γ-clusters, δ1- and δ2-subclusters) of H1 influenza A viruses, co-circulate in the US pig population, but have limited HI cross-reactivity between them. Antigenic cross-reactivity was limited between H1 clusters and supports the practice of combining multiple H1 viruses with H3N2 viruses in polyvalent vaccines used to control influenza in US swine population as well as many other regions around the world (http://www.aphis.usda.gov/animal_health/vet_biologics/publications/CurrentProdCodeBook.pdf). Established influenza viruses undergo antigenic drift in the swine host, allowing survival and selection of certain viral clusters in the host population. The H1 viruses will likely continue to mutate and evolve in the swine host as a consequence of evolutionary and immunological pressures, allowing evasion of the immune system of the host or only partially protective immunity. Further study is required to evaluate the usefulness of antigenic mapping for vaccine strain selection through experimental efficacy studies in pigs.

Our previous experiment (Vincent et al., 2010) demonstrated cross-reactivity using 2009 H1N1 as antigen and sera from pigs immunized with γ-cluster swine viruses from 2007 and 2008. The γ-cluster is the clade with which the HA from 2009 H1N1 is most closely related (Figs 2b and 3). Thus, prior exposure to some H1 swine subtypes is likely to provide some level of protection against infection with the 2009 human pandemic variant. This is also suggested by data from human epidemiological studies that showed high prevalence of neutralizing antibodies against 2009 pandemic H1N1 in people born before 1930 (Itoh et al., 2009; Munster et al., 2009). Moreover, immunization in mice with human H1N1 viruses that circulated before 1945 (e.g. specific antibodies against 1918 H1N1 or related viruses) is sufficient for immune protection from the 2009 pandemic H1N1 (Manicassamy et al., 2010).

The 2009 pandemic H1N1 underscores the potential risk to the human population from additional influenza virus subtypes and genotypes with the swine influenza TRIG backbone and demonstrates the potential for viruses with genes from swine lineages to emerge and cause human illness. However, all eight gene segments from the 2009 pandemic H1N1 formed clusters separate from US swine lineage viruses, suggesting neither the pandemic H1N1 nor closely related progenitor viral genes were present in influenza viruses from US swine prior to 2009.

Recent epidemiological data (M. R. Gramer and others, unpublished data) suggest that the number of swine influenza outbreaks in which δ-cluster viruses were recognized as causative agents increased in recent years (up to 40 % of isolated H1 swine influenza viruses in 2009 and early 2010), thus quickly becoming a dominant genotype in the USA. An expanded antigenic map with additional contemporary δ-cluster isolates and further investigation of their antigenic relationship with seasonal human viruses are therefore warranted.

The presence of typical ‘human-like’ residues in the receptor-binding pocket of the HA in two δ-cluster strains isolated from pigs demonstrates that swine viruses may efficiently preserve human-adapted phenotypes. The preservation of human-like residues in the swine host may allow potential novel reassortant influenza viruses to spill back into the human population, and this may be particularly important to consider for the δ-cluster swine viruses. Increased surveillance and monitoring by sequence and antigenic analysis of enzootic influenza viruses of swine as well as the 2009 pandemic H1N1 in the swine population worldwide are critical for understanding the dynamic ecology of influenza A viruses in this susceptible host population. Likewise, development of a vaccine strain selection system through surveillance and antigenic characterization of contemporary viruses is critical for controlling swine influenza viruses and reducing the risk of such reassortment events with the current 2009 pandemic H1N1 or other emerging viruses in the future.

METHODS

Virus selection.

Twelve H1N1 or H1N2 viruses representing each of the genetic clusters of subtype H1 from 2008 were received from the University of Minnesota Veterinary Diagnostic Laboratory (UMVDL) for use in this study. The viruses were isolated from outbreaks of respiratory disease in pigs from routine diagnostic cases submitted to the UMVDL. Viruses isolated in 2008 from the USA and Canada were selected from a database of 375 viral RNA sequences generated from diagnostic cases, each 900 nt long, of the H1 subtype (Table 1). The sequences were stored in a group database [Los Alamos National Laboratory, Influenza Sequence Database (http://www.flu.lanl.gov/)] and phylogenetic analyses were performed based on sequence alignment by the clustal w method using the megalign program from the Lasergene package (dnastar). From the phylogenetic analyses of the HA1 region of the HA gene, 12 viruses were selected for inclusion in this study to represent each of the H1 clusters of influenza viruses from North American swine circulating in 2008. Viruses were grown in Madin−Darby canine kidney (MDCK) cells in culture. Inactivated viruses for immunization were prepared at approximately 128 HA units per 50 μl (or maximum HA titre) with inactivation by UV irradiation and addition of a commercial adjuvant (Emulsigen D; MVP Laboratories) at a ratio of 4 : 1 (v/v) virus to adjuvant. Virus isolates contained in the inactivated vaccines and selected for full genome analysis are reported in Table 2. Similarly prepared immune sera from additional studies conducted at USDA NADC (Vincent et al., 2006, 2009a) were included in HI assays and antigenic mapping and are described in Table 2.

Table 1.

2008 UMVDL H1 swine influenza virus sequence dataset from which the 12 2008 H1 viruses were selected

Pig location α-Cluster β-Cluster γ-Cluster δ-Cluster Total
USA
Iowa 0 11 6 14 31
Illinois 3 6 26 8 43
Indiana 0 0 1 0 1
Kansas 1 4 2 4 11
Kentucky 0 5 0 0 5
Michigan 0 0 1 1 2
Minnesota 6 58 16 48 128
Missouri 6 13 7 3 29
North Carolina 0 2 30 18 50
Nebraska 0 7 1 2 10
Ohio 0 0 11 5 16
Oklahoma 0 5 0 16 21
South Dakota 1 0 2 1 4
Texas 0 2 1 7 10
Wisconsin 0 3 5 1 9
Canada
Manitoba 4 0 0 0 4
Saskatchewan 1 0 0 0 1
Total 22 116 109 128 375
Open in a new tab

Table 2.

2008 H1 swine influenza viruses (left column) included in the genetic and antigenic study and previous H1 swine influenza virus isolates used for the generation of antisera

Sequence GenBank accession numbers proceeding from segment gene 1 to segment gene 8 for each 2008 H1 isolate. Sw, Swine; p, pandemic.

2008 H1 GenBank accession nos Cluster Subtype NADC H1 Cluster Subtype
A/SW/MN/02053/2008 HM461759–HM461766 α H1N1 A/SW/MN/37866/1999 cH1 H1N1
A/SW/MN/02093/2008 HM461791–HM461798 α H1N1 A/SW/IA/1973 cH1 H1N1
A/SW/IA/02096/2008 HM461839–HM461846 β H1N1 A/SW/WI/1/1968 cH1 H1N1
A/SW/KY/02086/2008 HM461783–HM461790 β H1N1 A/SW/IA/1945 cH1 H1N1
A/SW/NE/02013/2008 HM461831–HM461838 β H1N1 A/SW/IA/15/1930 cH1 H1N1
A/SW/NC/02084/2008 HM461823–HM461830 β H1N1 A/SW/IA/00239/2004 β H1N1
A/SW/NC/02023/2008 HM461815–HM461822 γ H1N1 A/SW/NC/36883/2002 β H1N1
A/SW/OH/02026/2008 HM461775–HM461782 γ H1N1 A/SW/OH/511445/2007 γ H1N1
A/SW/MO/02060/2008 HM461807–HM461814 γ H1N1 A/SW/KS/00246/2004 γ H1N2
A/SW/TX/01976/2008 HM461847–HM461854 δ1 H1N2 A/SW/MN/00194/2003 γ H1N2
A/SW/IA/02039/2008 HM461767–HM461774 δ1 H1N2 A/SW/MN/1192/2001 γ H1N2
A/SW/MN/02011/2008 HM461799–HM461806 δ1 H1N2 A/SW/MN/07002083/2007 δ2 H1N1
A/SW/NC/00573/2005 δ2 H1N1
A/SW/IL/00685/2005 δ2 H1N1
A/SW/IL07003243/2007 δ1 H1N2
A/MX/4108/2009 2009p H1N1
A/CA/04/2009 2009p H1N1
A/SW/IL/5265/2009 2009p H1N1
A/SW/IL/32974/2009 2009p H1N1
A/SW/MN/8761/2010 2009p H1N1
Open in a new tab

454 genome sequencing technology.

The 12 selected viruses from clinical cases were grown at low passage number (P<5) in MDCK cell culture, concentrated and semi-purified on a 0.5 M sucrose cushion. Virus pellets were resuspended overnight at 4 °C in 0.5 ml STE buffer (10 mM NaCl, 10 mM Tris, pH 8.0 and 1 mM EDTA, pH 8.0). Resuspended virus samples were treated with 10 U RNase-free DNase I (Promega) and incubated for 10 min at room temperature, then treated with 500 U RNase inhibitor (RNase-In; Ambion) and 5 μl of 0.1 M dithiothreitol (Invitrogen). An equal volume of 2× LES buffer (0.2 M LiCl, 10 mM EDTA and 2.0 % SDS) was added to each sample, treated with 200 μg proteinase K (Invitrogen) and incubated for 30 min at 56 °C. Nucleic acid was extracted with phenol/chloroform and resuspended in 50 μl 10 mM Tris/HCl (pH 7.5) followed by library preparation for de novo pyrosequencing in a Genome Sequencer FLX system (454 Life Sciences) with the manufacturer's recommendations and reagents. Briefly, extracted viral RNA was fragmented, reverse transcribed and ligated to oligonucleotide adaptors containing MID labels. The MID-labelled viral cDNA samples were pooled and used to prepare sequencing beads via Roche's GS-FLX standard chemistry emulsion-based PCR. Each pool contained viral cDNA from three to five different viruses. Prepared beads were loaded onto 16 regions on a GS-FLX standard chemistry pico-titre plate according to manufacturer's recommendations and sequenced using the GS-FLX LR 70 standard chemistry. Sequencing reads were compared to an influenza database created from >85 000 influenza sequences extracted from GenBank in December, 2008. Using the blast results, influenza-specific sequencing reads were extracted and subsequently assembled with the Roche GS de novo Assembler (Newbler) version 2.0 software. Gene segments with large gaps were closed by traditional primer based sequencing using an ABI 3100 (Applied Biosystem) genetic analyser. The sequence contigs were analysed using SeqMan (dnastar). The 2008 H1 sequences generated were deposited into GenBank with the accession numbers proceeding from segment 1 to segment 8 as presented in Table 2. Human and swine influenza virus sequences adopted for the phylogenetic analysis were retrieved from the Influenza Virus Sequence Database (http://www.ncbi.nlm.nih.gov/genomes/FLU/Database/nph-select.cgi?go=database). For the HA and NA analyses, sequences recruitment was restricted to those exhibiting a minimum of 1000 nt. Sequence alignment for each individual gene segment and phylogenetic analyses were conducted using mega version 4 and the evolutionary distances were computed using the maximum composite likelihood method. Statistical support was provided by bootstrapping over 1000 replicates and bootstrap values >70 are indicated at the corresponding node (Tamura et al., 2007).

Animals, serological assay and antigenic cartography.

Four-week-old cross-bred pigs were obtained from a herd free of both influenza virus and porcine reproductive and respiratory syndrome virus (PRRSV) infections. Animals were housed, treated and screened for anti-influenza antibodies as described previously (Vincent et al., 2009b). Two pigs per virus were immunized with inactivated virus combined with commercial adjuvant by an intramuscular route. Two doses of vaccine were given approximately 2–3 weeks apart; pigs with HI titres <1 : 80 after the second dose were given a third dose of vaccine prior to final blood collection. At the end of the vaccination period, pigs were humanely euthanized with pentobarbital (Sleepaway; Fort Dodge Animal Health, Fort Dodge, IA) approximately 2 weeks after the final vaccination for blood collection.

Sera were heat inactivated at 56 °C and treated as described elsewhere (Vincent et al., 2010) and the HI assays were performed with turkey red blood cells with standard techniques (WHO Manual on Animal Influenza Diagnosis and Surveillance). The reciprocal of the ratio between heterologous and homologous HI titres for individual serum samples was calculated to indicate the fold-change between heterologous and homologous reactions.

The quantitative analyses of the antigenic properties of 2008 H1 viruses were performed using antigenic cartography. In an antigenic map, the distance between antiserum point S and antigen point A corresponds to the difference between the log2 of the maximum titre observed for antiserum S against any antigen and the log2 of the titre for antiserum S against antigen A. Therefore, each titre in an HI table can be thought of as specifying a target distance for the points in an antigenic map. Modified multidimensional scaling methods are then used to arrange the antigen and antiserum points in an antigenic map to best satisfy all the target distances specified by the HI data. The result is a map in which the distance between points best represents antigenic distance as measured by the HI assay. Because antisera are tested against multiple antigens, and antigens tested against multiple antisera, many measurements are used to determine the position of the antigen and antiserum points in an antigenic map, thus potentially increasing the accuracy of point placement beyond that of individual HI measurements.

Supplementary Material

Supplementary Tables
supp_92_4_919__index.html (1.6KB, html)

Acknowledgments

The authors acknowledge Tamara Beach for technical assistance and Brian Pottebaum and Jason Huegel for assistance with animal studies. The authors acknowledge Drs Matt Sandbulte and Lindomar Pena for critically reading the manuscript. Mention of trade names or commercial products in this article is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the US Department of Agriculture. Funding for this study was provided by USDA-ARS and from the National Pork Board grant #08-031. A. L. was supported by funds from an interagency agreement with DHHS-CDC; N. S. L. was supported by a Wellcome Trust Fellowship through grant WT089235MA; D. J. S. and C. A. R. were supported by an NIH Director's Pioneer Award, part of the NIH roadmap for medical research, through grant DP1-OD000490-01; 223498 EMPERIE, an FP7 grant from the European Union; program grant P0050/2008 from the Human Frontier Science Program and the Fogarty International Center, National Institutes of Health, Bethesda, Maryland, USA; and C. A. R. was also supported by a University Research Fellowship from the Royal Society, London and a research fellowship from Clare College, Cambridge.

Footnotes

The GenBank/EMBL/DDBJ accession numbers for the 2008 HI sequences from segment 1 to segment 8 are presented in Table 2.

Supplementary tables are available with the online version of this paper.

References

  1. Ayora-Talavera, G., Shelton, H., Scull, M. A., Ren, J., Jones, I. M., Pickles, R. J. & Barclay, W. S. (2009). Mutations in H5N1 influenza virus hemagglutinin that confer binding to human tracheal airway epithelium. PLoS ONE 4, e7836. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chen, W., Calvo, P. A., Malide, D., Gibbs, J., Schubert, U., Bacik, I., Basta, S., O'Neill, R., Schickli, J. & other authors (2001). A novel influenza A virus mitochondrial protein that induces cell death. Nat Med 7, 1306–1312. [DOI] [PubMed] [Google Scholar]
  3. Conenello, G. M., Zamarin, D., Perrone, L. A., Tumpey, T. & Palese, P. (2007). A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog 3, e141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dawood, F. S., Jain, S., Finelli, L., Shaw, M. W., Lindstrom, S., Garten, R. J., Gubareva, L. V., Xu, X., Bridges, C. B. & other authors (2009). Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360, 2605–2615. [DOI] [PubMed] [Google Scholar]
  5. de Jong, J. C., Smith, D. J., Lapedes, A. S., Donatelli, I., Campitelli, L., Barigazzi, G., Van Reeth, K., Jones, T. C., Rimmelzwaan, G. F. & other authors (2007). Antigenic and genetic evolution of swine influenza A (H3N2) viruses in Europe. J Virol 81, 4315–4322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. de Wit, E., Munster, V. J., van Riel, D., Beyer, W. E., Rimmelzwaan, G. F., Kuiken, T., Osterhaus, A. D. & Fouchier, R. A. (2010). Molecular determinants of adaptation of highly pathogenic avian influenza H7N7 viruses to efficient replication in the human host. J Virol 84, 1597–1606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Easterday, B. C. & van Reeth, K. (1999). Swine influenza. In Diseases of Swine, pp. 277–290. Edited by Straw, B. E., D'Allaire, S., Mengeling, W. L. & Taylor, D. J.. Ames, IA. : Iowa State University Press.
  8. Fouchier, R. A., Schneeberger, P. M., Rozendaal, F. W., Broekman, J. M., Kemink, S. A., Munster, V., Kuiken, T., Rimmelzwaan, G. F., Schutten, M. & other authors (2004). Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci U S A 101, 1356–1361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fouchier, R. A., Munster, V., Wallensten, A., Bestebroer, T. M., Herfst, S., Smith, D., Rimmelzwaan, G. F., Olsen, B. & Osterhaus, A. D. (2005). Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 79, 2814–2822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gao, Y., Zhang, Y., Shinya, K., Deng, G., Jiang, Y., Li, Z., Guan, Y., Tian, G., Li, Y. & other authors (2009). Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host. PLoS Pathog 5, e1000709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. García-Sastre, A., Egorov, A., Matassov, D., Brandt, S., Levy, D. E., Durbin, J. E., Palese, P. & Muster, T. (1998). Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252, 324–330. [DOI] [PubMed] [Google Scholar]
  12. Garten, R. J., Davis, C. T., Russell, C. A., Shu, B., Lindstrom, S., Balish, A., Sessions, W. M., Xu, X., Skepner, E. & other authors (2009). Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science 325, 197–201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Geiss, G. K., Salvatore, M., Tumpey, T. M., Carter, V. S., Wang, X., Basler, C. F., Taubenberger, J. K., Bumgarner, R. E., Palese, P. & other authors (2002). Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc Natl Acad Sci U S A 99, 10736–10741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hale, B. G., Steel, J., Medina, R. A., Manicassamy, B., Ye, J., Hickman, D., Hai, R., Schmolke, M., Lowen, A. C. & other authors (2010). Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 protein. J Virol 84, 6909–6922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hatta, M., Gao, P., Halfmann, P. & Kawaoka, Y. (2001). Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293, 1840–1842. [DOI] [PubMed] [Google Scholar]
  16. Höper, D., Hoffmann, B. & Beer, M. (2009). Simple, sensitive, and swift sequencing of complete H5N1 avian influenza virus genomes. J Clin Microbiol 47, 674–679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Huang, S. W., Hsu, Y. W., Smith, D. J., Kiang, D., Tsai, H. P., Lin, K. H., Wang, S. M., Liu, C. C., Su, I. J. & Wang, J. R. (2009). Reemergence of enterovirus 71 in 2008 in Taiwan: dynamics of genetic and antigenic evolution from 1998 to 2008. J Clin Microbiol 47, 3653–3662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Itoh, Y., Shinya, K., Kiso, M., Watanabe, T., Sakoda, Y., Hatta, M., Muramoto, Y., Tamura, D., Sakai-Tagawa, Y. & other authors (2009). In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460, 1021–1025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lamb, R. A. & Krug, M. A. (2007). Orthomyxoviridae: the viruses and their replication. In Fields Virology, 4th edn, pp. 1487–1531. Edited by Knipe, D. M. & Howley, P. M.. Philadelphia, PA. : Lippincott Williams & Wilkins.
  20. Le, Q. M., Kiso, M., Someya, K., Sakai, Y. T., Nguyen, T. H., Nguyen, K. H., Pham, N. D., Ngyen, H. H., Yamada, S. & other authors (2005). Avian flu: isolation of drug-resistant H5N1 virus. Nature 437, 1108. [DOI] [PubMed] [Google Scholar]
  21. Li, Z., Chen, H., Jiao, P., Deng, G., Tian, G., Li, Y., Hoffmann, E., Webster, R. G., Matsuoka, Y. & Yu, K. (2005). Molecular basis of replication of duck H5N1 influenza viruses in a mammalian mouse model. J Virol 79, 12058–12064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lipatov, A. S., Andreansky, S., Webby, R. J., Hulse, D. J., Rehg, J. E., Krauss, S., Perez, D. R., Doherty, P. C., Webster, R. G. & Sangster, M. Y. (2005). Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice: the role of cytokines and B- and T-cell responses. J Gen Virol 86, 1121–1130. [DOI] [PubMed] [Google Scholar]
  23. Long, J. X., Peng, D. X., Liu, Y. L., Wu, Y. T. & Liu, X. F. (2008). Virulence of H5N1 avian influenza virus enhanced by a 15-nucleotide deletion in the viral nonstructural gene. Virus Genes 36, 471–478. [DOI] [PubMed] [Google Scholar]
  24. Ma, W., Lager, K. M., Lekcharoensuk, P., Ulery, E. S., Janke, B. H., Solórzano, A., Webby, R. J., García-Sastre, A. & Richt, J. A. (2010). Viral reassortment and transmission after co-infection of pigs with classical H1N1 and triple-reassortant H3N2 swine influenza viruses. J Gen Virol 91, 2314–2321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Manicassamy, B., Medina, R. A., Hai, R., Tsibane, T., Stertz, S., Nistal-Villán, E., Palese, P., Basler, C. F. & García-Sastre, A. (2010). Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines. PLoS Pathog 6, e1000745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Marozin, S., Gregory, V., Cameron, K., Bennett, M., Valette, M., Aymard, M., Foni, E., Barigazzi, G., Lin, Y. & Hay, A. (2002). Antigenic and genetic diversity among swine influenza A H1N1 and H1N2 viruses in Europe. J Gen Virol 83, 735–745. [DOI] [PubMed] [Google Scholar]
  27. Matrosovich, M., Tuzikov, A., Bovin, N., Gambaryan, A., Klimov, A., Castrucci, M. R., Donatelli, I. & Kawaoka, Y. (2000). Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J Virol 74, 8502–8512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. McAuley, J. L., Hornung, F., Boyd, K. L., Smith, A. M., McKeon, R., Bennink, J., Yewdell, J. W. & McCullers, J. A. (2007). Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe 2, 240–249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Mehle, A. & Doudna, J. A. (2009). Adaptive strategies of the influenza virus polymerase for replication in humans. Proc Natl Acad Sci U S A 106, 21312–21316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Munster, V. J., de Wit, E., van den Brand, J. M., Herfst, S., Schrauwen, E. J., Bestebroer, T. M., van de Vijver, D., Boucher, C. A., Koopmans, M. & other authors (2009). Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science 325, 481–483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Neumann, G. & Kawaoka, Y. (2006). Host range restriction and pathogenicity in the context of influenza pandemic. Emerg Infect Dis 12, 881–886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Nicholls, J. M., Chan, R. W., Russell, R. J., Air, G. M. & Peiris, J. S. (2008). Evolving complexities of influenza virus and its receptors. Trends Microbiol 16, 149–157. [DOI] [PubMed] [Google Scholar]
  33. Park, A. W., Daly, J. M., Lewis, N. S., Smith, D. J., Wood, J. L. & Grenfell, B. T. (2009). Quantifying the impact of immune escape on transmission dynamics of influenza. Science 326, 726–728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Ramakrishnan, M. A., Tu, Z. J., Singh, S., Chockalingam, A. K., Gramer, M. R., Wang, P., Goyal, S. M., Yang, M., Halvorson, D. A. & Sreevatsan, S. (2009). The feasibility of using high resolution genome sequencing of influenza A viruses to detect mixed infections and quasispecies. PLoS ONE 4, e7105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Röhm, C., Zhou, N., Süss, J., Mackenzie, J. & Webster, R. G. (1996). Characterization of a novel influenza hemagglutinin, H15: criteria for determination of influenza A subtypes. Virology 217, 508–516. [DOI] [PubMed] [Google Scholar]
  36. Russell, C. A., Jones, T. C., Barr, I. G., Cox, N. J., Garten, R. J., Gregory, V., Gust, I. D., Hampson, A. W., Hay, A. J. & other authors (2008). The global circulation of seasonal influenza A (H3N2) viruses. Science 320, 340–346. [DOI] [PubMed] [Google Scholar]
  37. Salomon, R., Franks, J., Govorkova, E. A., Ilyushina, N. A., Yen, H. L., Hulse-Post, D. J., Humberd, J., Trichet, M., Rehg, J. E. & other authors (2006). The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04. J Exp Med 203, 689–697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Seo, S. H., Hoffmann, E. & Webster, R. G. (2002). Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat Med 8, 950–954. [DOI] [PubMed] [Google Scholar]
  39. Seo, S. H., Webby, R. & Webster, R. G. (2004). No apoptotic deaths and different levels of inductions of inflammatory cytokines in alveolar macrophages infected with influenza viruses. Virology 329, 270–279. [DOI] [PubMed] [Google Scholar]
  40. Shinya, K., Ebina, M., Yamada, S., Ono, M., Kasai, N. & Kawaoka, Y. (2006). Avian flu: influenza virus receptors in the human airway. Nature 440, 435–436. [DOI] [PubMed] [Google Scholar]
  41. Skehel, J. J. & Wiley, D. C. (2000). Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69, 531–569. [DOI] [PubMed] [Google Scholar]
  42. Smith, D. J., Lapedes, A. S., de Jong, J. C., Bestebroer, T. M., Rimmelzwaan, G. F., Osterhaus, A. D. & Fouchier, R. A. (2004). Mapping the antigenic and genetic evolution of influenza virus. Science 305, 371–376. [DOI] [PubMed] [Google Scholar]
  43. Spackman, E. & Suarez, D. L. (2008). Type A influenza virus detection and quantitation by real-time RT-PCR. Methods Mol Biol 436, 19–26. [DOI] [PubMed] [Google Scholar]
  44. Steel, J., Lowen, A. C., Mubareka, S. & Palese, P. (2009). Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N. PLoS Pathog 5, e1000252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Subbarao, E. K., London, W. & Murphy, B. R. (1993). A single amino acid in the PB2 gene of influenza A virus is a determinant of host range. J Virol 67, 1761–1764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Tamura, K., Dudley, J., Nei, M. & Kumar, S. (2007). mega4: Molecular Evolutionary Genetics Analysis (mega) software version 4.0. Mol Biol Evol 24, 1596–1599. [DOI] [PubMed] [Google Scholar]
  47. Tarendeau, F., Crepin, T., Guilligay, D., Ruigrok, R. W., Cusack, S. & Hart, D. J. (2008). Host determinant residue lysine 627 lies on the surface of a discrete, folded domain of influenza virus polymerase PB2 subunit. PLoS Pathog 4, e1000136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Van Hoeven, N., Pappas, C., Belser, J. A., Maines, T. R., Zeng, H., García-Sastre, A., Sasisekharan, R., Katz, J. M. & Tumpey, T. M. (2009). Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air. Proc Natl Acad Sci U S A 106, 3366–3371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Vincent, A. L., Lager, K. M., Ma, W., Lekcharoensuk, P., Gramer, M. R., Loiacono, C. & Richt, J. A. (2006). Evaluation of hemagglutinin subtype 1 swine influenza viruses from the United States. Vet Microbiol 118, 212–222. [DOI] [PubMed] [Google Scholar]
  50. Vincent, A. L., Ma, W., Lager, K. M., Janke, B. H. & Richt, J. A. (2008). Swine influenza viruses a North American perspective. Adv Virus Res 72, 127–154. [DOI] [PubMed] [Google Scholar]
  51. Vincent, A. L., Ma, W., Lager, K. M., Gramer, M. R., Richt, J. A. & Janke, B. H. (2009a). Characterization of a newly emerged genetic cluster of H1N1 and H1N2 swine influenza virus in the United States. Virus Genes 39, 176–185. [DOI] [PubMed] [Google Scholar]
  52. Vincent, A. L., Swenson, S. L., Lager, K. M., Gauger, P. C., Loiacono, C. & Zhang, Y. (2009b). Characterization of an influenza A virus isolated from pigs during an outbreak of respiratory disease in swine and people during a county fair in the United States. Vet Microbiol 137, 51–59. [DOI] [PubMed] [Google Scholar]
  53. Vincent, A. L., Lager, K. M., Faaberg, K. S., Harland, M., Zanella, E. L., Ciacci-Zanella, J. R., Kehrli, M. E., Jr, Janke, B. H. & Klimov, A. (2010). Experimental inoculation of pigs with pandemic H1N1 2009 virus and HI cross-reactivity with contemporary swine influenza virus antisera. Influenza Other Respir Viruses 4, 53–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Webster, R. G., Bean, W. J., Gorman, O. T., Chambers, T. M. & Kawaoka, Y. (1992). Evolution and ecology of influenza A viruses. Microbiol Rev 56, 152–179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Wise, H. M., Foeglein, A., Sun, J., Dalton, R. M., Patel, S., Howard, W., Anderson, E. C., Barclay, W. S. & Digard, P. (2009). A complicated message: identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J Virol 83, 8021–8031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Yamada, S., Hatta, M., Staker, B. L., Watanabe, S., Imai, M., Shinya, K., Sakai-Tagawa, Y., Ito, M., Ozawa, M. & other authors (2010). Biological and structural characterization of a host-adapting amino acid in influenza virus. PLoS Pathog 6, e1001034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Zamarin, D., Ortigoza, M. B. & Palese, P. (2006). Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J Virol 80, 7976–7983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Zhou, N. N., Senne, D. A., Landgraf, J. S., Swenson, S. L., Erickson, G., Rossow, K., Liu, L., Yoon, K., Krauss, S. & Webster, R. G. (1999). Genetic reassortment of avian, swine, and human influenza A viruses in American pigs. J Virol 73, 8851–8856. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Zhu, H., Wang, J., Wang, P., Song, W., Zheng, Z., Chen, R., Guo, K., Zhang, T., Peiris, J. S. & Chen, H. (2010). Substitution of lysine at 627 position in PB2 protein does not change virulence of the 2009 pandemic H1N1 virus in mice. Virology 401, 1–5. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Tables
supp_92_4_919__index.html (1.6KB, html)
supp_92.4.919_Supplementary_tables.pdf (117.7KB, pdf)

Articles from The Journal of General Virology are provided here courtesy of Microbiology Society

RESOURCES